9. COMPOSITION, RESPONSIBILITIES, PROCEDURES OF INSTITUTIONAL REVIEW BOARD (IRB)
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ COMPOSITION, RESPONSIBILITIES, PROCEDURES OF INSTITUTIONAL REVIEW BOARD (IRB).
8. ETHICAL GUIDELINES IN CLINICAL RESEARCH
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ ETHICAL GUIDELINES IN CLINICAL RESEARCH.
7. CHALLENGES IN THE IMPLEMENTATION OF GUIDELINES
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ CHALLENGES IN THE IMPLEMENTATION OF GUIDELINES.
6. GOOD CLINICAL PRACTICE – CDSCO GUIDELINES
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ GOOD CLINICAL PRACTICE – CDSCO GUIDELINES.
5. GOOD CLINICAL PRACTICE – ICH, GCP
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ GOOD CLINICAL PRACTICE – ICH, GCP
4. METHODS OF POST MARKETING SURVEILLANCE
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ METHODS OF POST MARKETING SURVEILLANCE.
3. VARIOUS PHASES OF CLINICAL TRIAL
PATH: PHARMD/ PHARMD NOTES/ PHARMD FIFTH YEAR NOTES/ CLINICAL RESEARCH/ VARIOUS PHASES OF CLINICAL TRIAL.
